News

The AMA has shifted from a behind-the-scenes lobbying strategy to more forceful public advocacy against President Trump's ...
A new study suggests that, after having a specialized AI tool taken away, clinicians were less proficient at colonoscopies.
In at least six internal calls on Monday, CDC employees told leaders they worried that the agency wasn’t prepared for future ...
An all-hands meeting at the CDC to discuss the attack on the agency on Friday was brief and chaotic, staffers say.
Insmed has received FDA clearance for the first treatment for a chronic lung disease, opening the biotech up to what could be ...
This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Ambient scribe company Abridge, partnering with Highmark Health, says it can give information on prior authorization during, ...
Issues are piling up on Kennedy's watch, from responding to the CDC shooting to infighting over an FDA official.
Pfizer said its antibody-drug conjugate Padcev extended survival when combined with the immunotherapy Keytruda in some ...
So is a 500,000-square-foot lab building up the street, as well as one in Boston near Fenway Park. A sprawling complex on ...
A company that has Donald Trump Jr. on its board debuted a new service to help pharmaceutical companies launch direct sales ...